Why the National Veterinary Care Ltd share price has risen 31% in 2017

The National Veterinary Care Ltd share price has grown strongly this year.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The National Veterinary Care Ltd (ASX: NVL) share price has risen by 31% since the start of the year, soundly beating the market. The share price has risen by 4.44% today.

National Veterinary Care is a rapidly-expanding veterinary clinic operator, which has grown from a single clinic in 2015 to dozens today.

The pet industry has pleasing characteristics thanks to a growing pet (and human) population, increased spending due to the humanisation of pets and defensive earnings because of how much we value our pets over most other things in our lives.

Prior to the recent acquisition announcement National Veterinary Care had already expanded its clinic numbers by 13.2% since 1 July 2017.

However, this number will grow even further thanks to an acquisition pipeline which was announced on 18 December 2017.

National Vet Care announced that it has entered into binding agreements to acquire four more clinics in Australia. The agreements are conditional on final due diligence, board approval and lease agreements. It's expected these clinics will settle by 28 February 2018.

The new clinics are located inside existing National Vet Care geographic clusters in Queensland and Victoria. They will use and benefit from the operational structure that National Veterinary Care has built upon over the last 12 months.

Together, the four clinics are expected to add annual revenue of $4.5 million and earnings before interest and tax of $0.79 million. Management expect the clinics to add to FY18 earnings per share.

The total cost of these four acquisitions will be $3.6 million, including $320,000 in scrip.

Foolish takeaway

Management had already predicted statutory revenue growth of 25% before this announcement, so I expect revenue growth could be up to 30% by the end of the year.

I think National Vet Care is one of the top small caps to own, which is why I'm a happy shareholder.

Motley Fool contributor Tristan Harrison owns shares of NATVETCARE FPO. The Motley Fool Australia owns shares of NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »